| CTCSX | WCMNX | CTCSX / WCMNX | |
| Total Expense Ratio | 2.05 | 1.24 | 165% |
| Annual Report Gross Expense Ratio | 2.10 | 2.04 | 103% |
| Fund Existence | 4 years | 6 years | - |
| Gain YTD | 16.074 | 5.674 | 283% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 486M | 44.8M | 1,085% |
| Annual Yield % from dividends | 1.69 | 0.00 | - |
| Returns for 1 year | 29.97 | 4.52 | 663% |
| Returns for 3 years | 55.67 | 21.91 | 254% |
| Returns for 5 years | N/A | 15.60 | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ACES | 29.81 | 0.21 | +0.71% |
| ALPS Clean Energy ETF | |||
| NXTG | 101.27 | 0.63 | +0.62% |
| First Trust IndXX NextG ETF | |||
| HELX | 29.85 | 0.13 | +0.45% |
| Franklin Genomic Advancements ETF | |||
| LTTI | 19.37 | 0.08 | +0.39% |
| FT Vest 20+ Year Treasury & Target Income ETF | |||
| MDYV | 84.08 | -0.18 | -0.21% |
| SPDR® S&P 400 Mid Cap Value ETF | |||